HRA Pharma has submitted an application for what would become the first-ever over-the-counter birth control pill in the United States, if approved by the FDA.
“This historic application marks a groundbreaking moment in contraceptive access and reproductive equity,” Frédérique Welgryn, chief strategic operations and innovation officer at HRA Pharma, said in a press release.
The company applied for a prescription-to-OTC switch for Opill, a progestin-only daily birth control pill that consists of 0.075 mg norgestrel, according to the release, “and has been used to